Haibo Li

Dr. Haibo Li

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2018 in Journal of International Medical Research
Verified
Journal Article
Open access
JXJingjing Xiang
Jingjing Xiang
WWWei Wang
Wei Wang
CQChunfeng Qian
Chunfeng Qian
JXJiangyang Xue
Jiangyang Xue
TWTing Wang
Ting Wang
HLHong Li
Hong Li
To explore the etiology of human oocyte maturation arrest in two infertile Chinese sisters. Clinical examination and genetic testing of all available family members were conducted, and the findings were used to create a pedigree. Mutation screening using PCR amplification and DNA Sanger sequencing of the entire tubulin beta 8 class VIII gene (TUBB8) including intron–exon boundaries was performed to identify mutations. A novel missense TUBB8 mutation (c.1054G > T, p.A352S) in the patient and her elder sister was detected and shown to be associated with oocyte maturation arrest. Our findings expand the known mutation spectrum of TUBB8 and provide insights into the etiology of human oocyte maturation arrest.

6 November 2021 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
RRRong Rong
Rong Rong
RYRongliang Yang
Rongliang Yang
HLHaibo Li
Haibo Li
MYMengling You
Mengling You
ZLZhuotao Liang
Zhuotao Liang
JJi Dan
Ji Dan

1 December 2021 in Translational Pediatrics
Verified
Journal Article
Open access
PDF file
JXJiangyang Xue
Jiangyang Xue
RSRu Shen
Ru Shen
MXMin Xie
Min Xie
YLYingwen Liu
Yingwen Liu
YZYuxin Zhang
Yuxin Zhang
HLHaibo Li
Haibo Li
22q11.2 recurrent copy number variation-related syndrome: a retrospective analysis of our own microarray cohort and a systematic clinical overview of ClinGen curation Jiangyang Xue, Ru Shen, Min Xie, Yingwen Liu, Yuxin Zhang, Linglu Gong, Haibo Li

6 December 2023 in Reviews in Endocrine and Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
RVRexhina Vlashi
Rexhina Vlashi
XZXingen Zhang
Xingen Zhang
HLHaibo Li
Haibo Li
GCGUIQIAN CHEN
GUIQIAN CHEN

22 March 2024 in Clinical Chemistry
Verified
Journal Article
Open access
PDF file
MXMin Xie
Min Xie
ZZZhao-Jing Zheng
Zhao-Jing Zheng
YZYing Zhou
Ying Zhou
YZYu-Xin Zhang
Yu-Xin Zhang
QLQiong Li
Qiong Li
HLHaibo Li
Haibo Li
Background: Optical genome mapping (OGM) is a novel assay for detecting structural variants (SVs) and has been retrospectively evaluated for its performance. However, its prospective evaluation in prenatal diagnosis remains unreported. This study aimed to prospectively assess the technical concordance of OGM with standard of care (SOC) testing in prenatal diagnosis. Methods: A prospective cohort of 204 pregnant women was enrolled in this study. Amniotic fluid samples from these women were subjected to OGM and SOC testing, which included chromosomal microarray analysis (CMA) and karyotyping (KT) in parallel. The diagnostic yield of OGM was evaluated, and the technical concordance between OGM and SOC testing was assessed. Results: OGM successfully analyzed 204 cultured amniocyte samples, even with a cell count as low as 0.24 million. In total, 60 reportable SVs were identified through combined OGM and SOC testing, with 22 SVs detected by all 3 techniques. The diagnostic yield for OGM, CMA, and KT was 25% (51/204), 22.06% (45/204), and 18.14% (37/204), respectively. The highest diagnostic yield (29.41%, 60/204) was achieved when OGM and KT were used together. OGM demonstrated a concordance of 95.56% with CMA and 75.68% with KT in this cohort study. Conclusions: Our findings suggest that OGM can be effectively applied in prenatal diagnosis using cultured amniocytes and exhibits high concordance with SOC testing. The combined use of OGM and KT appears to yield the most promising diagnostic outcomes.

12 January 2016 in Molecular Cytogenetics
Verified
Journal Article
Open access
PDF file
TWting wang
ting wang
CDChengying Duan
Chengying Duan
CSCong Shen
Cong Shen
JXJingjing Xiang
Jingjing Xiang
QHQuanze He
Quanze He
LZLili Zhang
Lili Zhang
To detect complex fetal subchromosomal abnormalities by noninvasive prenatal testing (NIPT). After routine prenatal serum screening, the plasma of high-risk pregnant women were tested via NIPT, and the NIPT results were further validated by fetal karyotype analysis and array-based comparative genomic hybridization (aCGH) through amniocentesis. In addition, the chromosome karyotypes of the parents were also analyzed. NIPT results indicated subchromosomal abnormalities in chromosomes 13 and 21; aCGH results showed 22 Mb and 16 Mb deletions in 13 q31.3 - q34 and 21q11.1 - q21.3, respectively; and the fetal karyotype was 45,XX, der(13),-21. The maternal karyotype 46,XX,inv(9)(p12q13),t(13;21)(q31.3;q21.3) was abnormal, while the paternal karyotype showed no obvious abnormality. In this study, we successfully detected complex deletions in chromosomes 13 and 21 in a fetus using NIPT, and NIPT can provide effective genetic information for the detection of fetal subchromosomal abnormalities.